Korean Drug Co. Ltd (014570) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.046x

Based on the latest financial reports, Korean Drug Co. Ltd (014570) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.72 Billion ≈ $2.52 Million USD) by net assets (₩81.04 Billion ≈ $54.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Korean Drug Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Korean Drug Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Korean Drug Co. Ltd for a breakdown of total debt and financial obligations.

Korean Drug Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Korean Drug Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
eMnet Inc KQ:123570	-0.022x
MedMira Inc V:MIR	0.011x
Axita Cotton Limited NSE:AXITA	0.009x
Asf Group Ltd AU:AFA	-0.345x
Asian Hotels (East) Limited NSE:AHLEAST	0.039x
Research Frontiers Incorporated NASDAQ:REFR	-0.499x
Haiwan International Development Co Ltd TWO:3252	0.019x
Alam Maritim Resources Bhd KLSE:5115	-0.221x

Annual Cash Flow Conversion Efficiency for Korean Drug Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Korean Drug Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Korean Drug Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩78.11 Billion ≈ $52.93 Million	₩4.87 Billion ≈ $3.30 Million	0.062x	+340.45%
2023-12-31	₩77.09 Billion ≈ $52.24 Million	₩-2.00 Billion ≈ $-1.35 Million	-0.026x	-137.14%
2022-12-31	₩84.71 Billion ≈ $57.41 Million	₩5.91 Billion ≈ $4.01 Million	0.070x	-39.22%
2021-12-31	₩76.69 Billion ≈ $51.97 Million	₩8.81 Billion ≈ $5.97 Million	0.115x	-34.00%
2020-12-31	₩70.87 Billion ≈ $48.03 Million	₩12.33 Billion ≈ $8.36 Million	0.174x	+82.29%
2019-12-31	₩65.05 Billion ≈ $44.08 Million	₩6.21 Billion ≈ $4.21 Million	0.095x	+3.56%
2018-12-31	₩62.80 Billion ≈ $42.56 Million	₩5.79 Billion ≈ $3.92 Million	0.092x	+1074.16%
2017-12-31	₩56.97 Billion ≈ $38.61 Million	₩447.20 Million ≈ $303.06K	0.008x	-89.37%
2016-12-31	₩53.66 Billion ≈ $36.37 Million	₩3.96 Billion ≈ $2.69 Million	0.074x	-40.18%
2015-12-31	₩49.68 Billion ≈ $33.67 Million	₩6.13 Billion ≈ $4.16 Million	0.123x	+34.95%
2014-12-31	₩48.79 Billion ≈ $33.06 Million	₩4.46 Billion ≈ $3.02 Million	0.091x	--

About Korean Drug Co. Ltd

KQ:014570 Korea Drug Manufacturers - General

Market Cap

$30.25 Million

₩44.63 Billion KRW

Market Cap Rank

#23681 Global

#1707 in Korea

Share Price

₩4125.00

Change (1 day)

-1.55%

52-Week Range

₩3765.00 - ₩4975.00

All Time High

₩13030.58